Skip to main content
Sunovion logo
  • Health Care Professionals
  • Patients
  • Media
  • Contact Us
  • Sumitomo Dainippon Pharma
  • ENGLISH
    US
    ENGLISH
    EUROPE
    ENGLISH
    CANADA
    ENGLISH FRENCH
    GLOBAL
    ENGLISH
  • Who We Are
    • Who We are overview
    • Our Mission, Vision & Values
    • Executive Leadership
      • Nobuhiko Tamura
      • Greg Bokar
      • Matthew D'Ambrosio
      • David Frawley
      • Stephen Freeman
      • Robert Gregorio
      • Antony Loebel
    • Our History
    • Our People
      • Jeffrey Akin
      • Robin Cruz
      • John Gallo
      • Katrina Iserman
      • Henry McMillan
      • Daniel Yi
    Person photo

    Our employees strive to make a difference in people’s lives

    Meet the people of Sunovion
    Lab photo

    See what we're working on

    Learn more about our Pipeline
    Paper photo

    Get our latest news

    View our Press Releases
  • Join Us
    • Join us overview
    • Benefits
    • Job Search
    • Special Programs
    • General Warning to Job Seekers
    Chart photo

    Our career paths offer you opportunities

    See where your career can take you at Sunovion
    Person photo

    About Sunovion

    Who We Are
    Scientists photo

    Career Opportunities

    Learn more about our career opportunities
  • Responsibility
    • Responsibility overview
    • Patient Support & Advocacy
    • Community Building
    Working man photo

    Responsibility

    Hands On! Day
    Person photo

    About Sunovion

    Who We Are
    Scientists photo

    Career Opportunities

    Learn more about our career opportunities
  • Our Therapies
    • OUR THERAPIES OVERVIEW
    • Aptiom® (eslicarbazepine acetate) tablets
    • Brovana® (aformoterol tartrate) Inhalation Solution
    • KYNMOBITM (apomorphine HCl) sublingual film
    • Latuda® (lurasidone HCi) tablets
    • Lonhala® Magnair® (glycopyrrolate) Inhalation Solution
    • Lunesta® (eszopiclone) tablets
    • Xopenex® HFA (levalbuterol tartrate) Inhalation Aerosol
    Family photo

    Our Therapies

    Find out more about our medications today
    Lab photo

    Pipeline

    Learn more about our treatments for
    tomorrow
    Therapies photo

    CNS Overview

    See how we're treating neurological disorders
  • Research & Development
    • Research & Development overview
    • Our Pipeline
    • Psychiatric Disorders Overview
    • Neurological Disorders Overview
    • Respiratory Disorders Overview
    • Research Grants
    • Disclosure of Clinical Study Data
    Family photo

    Condition Focus

    Bipolar Disorder
    Anthony Loebel photo

    Meet Our Leaders

    Antony Loebel, MD, President and Chief Executive Officer
    Scientist photo

    Research Grants

    Independent Medical Research Grants
  • Explore Partnerships
    • Explore Partnerships Overview
    • Our Partners
    • Partnering Contact Form
    Scientists photo

    Our Approach to Partnership

    See how we're collaborating with partners
    Scientists photo

    Our Partners

    See where we're developing advanced medical therapies
    Scientist photo

    How We Create Value

    Explore the types of partnerships we're looking for
  • Featured News
    Person photo

    Our employees strive to make a difference in people’s lives

    Meet the people of Sunovion
    Notebook photo

    Sunovion Fast Facts

    Media Kit
    Person photo

    About Sunovion

    Who We Are
Sunovion logo
  • Featured News Overview
    • Press Releases
ENGLISH
US
ENGLISH
EUROPE
ENGLISH
CANADA
ENGLISH FRENCH
GLOBAL
ENGLISH
  • Home
  • Who We Are
    • Who We are overview
    • Our Mission, Vision & Values
    • Executive Leadership
      • Nobuhiko Tamura
      • Greg Bokar
      • Matthew D'Ambrosio
      • David Frawley
      • Stephen Freeman
      • Robert Gregorio
      • Antony Loebel
    • Our History
    • Our People
      • Jeffrey Akin
      • Robin Cruz
      • John Gallo
      • Katrina Iserman
      • Henry McMillan
      • Daniel Yi
  • Join Us
    • Join us overview
    • Benefits
    • Job Search
    • Special Programs
    • General Warning to Job Seekers
  • Responsibility
    • Responsibility overview
    • Patient Support & Advocacy
    • Community Building
  • Our Therapies
    • Oor Therapies Overview
    • Aptiom® (eslicarbazepine acetate) tablets
    • Brovana® (aformoterol tartrate) Inhalation Solution
    • Latuda® (lurasidone HCi) tablets
    • Lonhala® Magnair® (glycopyrrolate) Inhalation Solution
    • Lunesta® (eszopiclone) tablets
    • Xopenex® HFA (levalbuterol tartrate) Inhalation Aerosol
  • Research & Development
    • Research & Development overview
    • Our Pipeline
    • Psychiatric Disorders Overview
    • Neurological Disorders Overview
    • Respiratory Disorders Overview
    • Research Grants
    • Disclosure of Clinical Study Data
  • Explore Partnerships
    • Explore Partnerships Overview
    • Our Partners
    • Partnering Contact Form
  • Featured News
  • Health Care Professionals
  • Our Patients
  • Media
  • Contact Us

Follow us on:

  • Featured News Overview
    • Press Releases

Featured News

All press releases

Media

Search Sunovion Newsroom Learn More in Our Media Kit Contact Sunovion

Our Mission, Vision & Values

Learn about Sunovion’s mission, vision and values Responsibility at Sunovion

Our History

Discover more about Sunovion's history Executive Leadership
Page Sources

Email Alerts

Be the first to know the latest news about all things Sunovion

Click here to sign up for and manage email alerts
Email Alerts image
  • Health Care Professionals
  • Patients
  • Media
  • Corporate Documents
  • Join Us
  • Sunovion Parent Company:
    Sumitomo Dainippon Pharma

FOLLOW US ON:

  • Terms of Use
  • Privacy Policy and Cookie Notice
  • Medical Disclaimer
  • Sources

SUNOVION and Sunovion logo are registered trademarks of Sumitomo Dainippon Pharma Co., Ltd. Sunovion Pharmaceuticals Inc. is a U.S. subsidiary of Sumitomo Dainippon Pharma Co., Ltd.

LUNESTA, Lunesta logo, XOPENEX HFA, and BROVANA are registered trademarks of Sunovion Pharmaceuticals Inc.

APTIOM is a registered trademark of Bial logo, used under license. LATUDA is a registered trademark of Sumitomo Dainippon Pharma Co., Ltd.

LONHALA is a registered trademark and Lonhala logo is a trademark of Sunovion Pharmaceuticals Inc. MAGNAIR is a registered trademark of PARI Pharma GmbH, used under license.

eFlow and eLete are registered trademarks of PARI Pharma GmbH.

KYNMOBI and Sunovion logo are trademarks of Sunovion Pharmaceuticals Inc.

Powered By Q4 Inc. 5.39.0.1 (opens in new window)